Breaking News Instant updates and real-time market news.

NCLH

Norwegian Cruise Line

$56.69

-1.85 (-3.16%)

, RCL

Royal Caribbean

$118.73

-0.31 (-0.26%)

12:44
09/06/17
09/06
12:44
09/06/17
12:44

On The Fly: Top stock stories at midday

Stocks opened with solid gains as the market attempts to recoup some of its losses from yesterday's selloff. The averages have moved in a fairly narrow range during the morning session but the Nasdaq has given up about all of its early gains. Investors are waiting on the release of the Fed's Beige Book report this afternoon and more news about the impending storm expected to hit Florida. ECONOMIC EVENTS: In central bank news, Stanley Fischer submitted his resignation as Vice Chairman and as a member of the Board of Governors of the Federal Reserve, citing "personal reasons" in his resignation letter to President Trump. Additionally, the Bank of Canada raised its target for the overnight rate to 1%. In terms of U.S. data, the ISM nonmanufacturing index bounced 1.4 points to 55.3 in August. Markit's final August services PMI rose 1.3 points to 56.0, up from 54.7 in July but down from the 56.9 preliminary August print. The trade deficit widened 0.3% to $43.7B in July after narrowing to $43.5B in June. Exports dipped 0.3%, while imports slipped 0.2%. However, the July deficit was $0.9B narrower than indicated by the "advance" trade report. In Europe, German factory orders for July fell short of expectations, dropping 0.7% month-over-month compared to expectations for a mild monthly increase. COMPANY NEWS: Shares of cruise line operators were in focus amid concerns about the potential impact of Hurricane Irma on the cruise and travel industries, as well as the lingering effect of Hurricane Harvey. Irma, which has intensified into a Category 5 storm, if forcing cruise operators to cancel or divert ships as it heads towards the Caribbean and the Florida coast. Norwegian (NCLH) shares were down 0.6%, Carnival shares were 0.2% lower, and Royal Caribbean (RCL) shares fell 0.3%... Meanwhile, shares of Gap (GPS) surged 6% after the retailer said it will provide an overview of its growth strategy at the Goldman Sachs Annual Global Retailing Conference, noting that the company expects about $500M in expense savings over the next three years by better leveraging its size and scale, cross-brand synergies and streamlining operations and processes. The company added that it expects to add about 70 net new stores over the next three years, with the addition of roughly 270 Old Navy, Athleta and value expressions across the portfolio, and the closure of about 200 underperforming Gap and Banana Republic specialty locations... Additionally, HP Enterprise (HPE) shares were 2.5% lower at midday after the company reported better than expected quarterly results but cut its fiscal 2017 earnings per share outlook. MAJOR MOVERS: Among the noteworthy gainers was Electronics for Imaging (EFII), which rose 14% after the company provided better than expected guidance for the third quarter and noted that "significant additional progress" has been made relating to the timing of revenue recognition. Also higher was Sarepta (SRPT), which gained 13% after it announced "positive" results from its 4053-101 study to assess the safety, tolerability, pharmacokinetics, and efficacy of golodirsen. Among the notable losers was trivago (TRVG), which fell 16% after the company cut its fiscal 2017 revenue growth guidance. Also lower after reporting quarterly results was Dave & Buster's (PLAY), which fell nearly 10%. INDEXES: Near midday, the Dow was up 58.51, or 0.27%, to 21,811.82, the Nasdaq was up 4.39, or 0.07%, to 6,379.96, and the S&P 500 was up 5.54, or 0.23%, to 2,463.39.

NCLH

Norwegian Cruise Line

$56.69

-1.85 (-3.16%)

RCL

Royal Caribbean

$118.73

-0.31 (-0.26%)

CCL

Carnival

$66.82

-0.15 (-0.22%)

CUK

Carnival plc

$67.44

-0.28 (-0.41%)

GPS

Gap

$25.52

1.49 (6.20%)

HPE

HP Enterprise

$13.76

-0.28 (-1.99%)

EFII

Electronics for Imaging

$35.25

-0.36 (-1.01%)

SRPT

Sarepta

$41.08

-0.15 (-0.36%)

TRVG

trivago

$14.93

-0.58 (-3.74%)

PLAY

Dave & Buster's

$58.14

0.3 (0.52%)

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 27

    Sep

NCLH Norwegian Cruise Line
$56.69

-1.85 (-3.16%)

08/04/17
STFL
08/04/17
NO CHANGE
STFL
Norwegian Cruise Line should deliver beat and raise results, says Stifel
Stifel analyst Steven Wieczynski says that the results and comments of Royal Caribbean (RCL) and Carnival (CCL) indicate that Norwegian Cruise Line (NCL) will report beat and raise Q2 results. The analyst expects Norwegian, like Royal Caribbean and Carnival, to benefit from higher prices. He also expects Norwegian to be boosted by a reduction of "operational headwinds" which should enable its yield to rise more than that of its peers in 2018. The analyst keeps a $60 price target and a Buy rating on Norwegian.
08/02/17
GSCO
08/02/17
UPGRADE
Target $115
GSCO
Neutral
Royal Caribbean upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Stephen Grambling upgraded Royal Caribbean (RCL) to Neutral citing "strong" leisure trends following the company's better than expected Q2 results. The analyst says his sell thesis has failed to materialize. He raised his price target for the shares to $115 from $99. Grambling also raised his price target for Neutral-rated Carnival (CCL) to $68 from $60 and for Neutral-rated Norwegian Cruise Line (NCLH) to $60 from $55.
07/24/17
BOFA
07/24/17
INITIATION
Target $65
BOFA
Buy
Norwegian Cruise Line initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Andrew Didora initiated Norwegian Cruise Line with a Buy and a $65 price target saying shares trade at a discount to peers despite solid net yield trends, a newer fleet, and high margins.
05/26/17
WEDB
05/26/17
UPGRADE
WEDB
Outperform
Norwegian Cruise Line upgraded to Outperform from Neutral at Wedbush
RCL Royal Caribbean
$118.73

-0.31 (-0.26%)

08/02/17
08/02/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) upgraded to Outperform from Market Perform at BMO Capital with analyst Alex Arfaei saying he expects "positive updates" on the company's pipeline that could improve investors' view on the company. 2. Royal Caribbean (RCL) upgraded to Neutral from Sell at Goldman Sachs with analyst Stephen Grambling citing "strong" leisure trends following the company's better than expected second quarter results. 3. Illumina (ILMN) upgraded to Equal-Weight from Underweight at First Analysis with analyst Joseph Munda saying concerns regarding sequencing overcapacity in the marketplace and the potential rate of adoption for NovaSeq are diminishing based on performance in the quarter. 4. Agios Pharmaceuticals (AGIO) upgraded to Outperform from Market Perform at Leerink with analyst Michael Schmidt citing his higher-level conviction regarding the commercial opportunity for its IDH inhibitors Idhifa and ivosidenib in acute myeloid leukemia following Idhifa FDA-approval and his recent checks indicating a high degree of enthusiasm for these agents in the physician community pointing to potential good initial uptake. 5. Sonoco Products (SON) upgraded to Hold from Sell at Vertical Research with analyst Chip Dillion citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/25/17
STFL
07/25/17
NO CHANGE
STFL
Royal Caribbean should be bought on any 'irrational' weakness, says Stifel
Stifel analyst Steven M. Wieczynski does not expect Royal Caribbean's Q2 results to significantly beat expectations, and he thinks investors' expectations for the results may be "unrealistic," particularly regarding the anticipation of increases in the company's 2017 guidance. However, he recommends buying the stock on any "irrational" weakness following the results, as he thinks that the company's 2018 results could beat his expectations and expects the company's multiple and capital returns to increase. He keeps a $125 price target and a Buy rating on the stock.
CCL Carnival
$66.82

-0.15 (-0.22%)

07/24/17
BOFA
07/24/17
INITIATION
Target $73.2
BOFA
Buy
Carnival resinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Andrew Didora reinstated Carnival with a Buy and a $73.20 price target expects earnings momentum to continue driven by strong demand and a subdued supply backdrop.
08/17/17
UBSW
08/17/17
NO CHANGE
Target $76
UBSW
Buy
Carnival price target raised to $76 from $67 at UBS
UBS analyst Robin Farley raised her price target on Carnival to $76 from $67. The analyst noted guidance for the second half of the year is only up 1-2% but he believes the company is being conservative given tougher comps and the uncertainty around any travel incidents when looking out six months. Farley reiterated her Buy rating on Carnival shares.
CUK Carnival plc
$67.44

-0.28 (-0.41%)

09/29/16
09/29/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Owens Corning (OC) initiated with a Market Perform at Wells Fargo. 2. Kate Spade (KATE) was initiated with an Outperform at CLSA, while the firm initiated Coach (COH) with a Buy and Michael Kors (KORS) with a Sell. 3. RetailMeNot (SALE) and Groupon (GRPN) initiated with a Neutral at Boenning & Scattergood. 4. Carnival (CCL) initiated with a Hold at Deutsche Bank. 5. D.R. Horton (DHI) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/06/17
BERN
01/06/17
NO CHANGE
Target $63
BERN
Outperform
Carnival OCEAN platform to be 'powerful competitive advantage,' says Bernstein
Bernstein analyst David Beckel said Carnival's OCEAN "connected experience" platform, unveiled at CES 2017, could, and likely will, be emulated to some extent across the entire travel industry. However, citing Carnival's head start, scale, and technology expertise, he sees OCEAN becoming a "powerful competitive advantage for the company for years to come." Beckel keeps his Outperform rating and $63 price target on Carnival shares.
GPS Gap
$25.52

1.49 (6.20%)

09/01/17
SBSH
09/01/17
UPGRADE
Target $24
SBSH
Neutral
Gap upgraded to Neutral from Sell at Citi
Citi analyst Paul Lejuez upgraded Gap to Neutral citing low expectations and support from the 4% dividend yield. Concerns of a slowdown at Old Navy appear more priced in at current valuation levels, Lejuez tells investors in a research note. He raised his price target for the shares to $24 from $22. Gap closed yesterday up 14c to $23.62.
08/18/17
JEFF
08/18/17
NO CHANGE
Target $35
JEFF
Buy
Gap posted solid quarter in tough environment, says Jefferies
Jefferies analyst Randal Konik views Gap's Q2 results as solid amid a tough operating environment for retailers. The company's beat was high quality, with upside on comps and gross margin, Konik tells investors in a post-earnings research note. He notes Q2 was the third consecutive quarter of positive comps. The analyst reiterates a Buy rating on Gap with a $35 price target.
08/18/17
UBSW
08/18/17
NO CHANGE
Target $23
UBSW
Sell
Gap beat expectations but downside risk remains, says UBS
UBS analyst Michael Binetti said Gap had solid Q2 results but he does not see signs of a sustainable earnings acceleration. The analyst sees downside risk from gross margins and SG&A pressure in the second half of the year but raised his estimates slightly due to the Q2 beat. Binetti reiterated his Sell rating and $23 price target on Gap shares.
09/01/17
09/01/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Palo Alto Networks (PANW) was upgraded to Overweight from Neutral at JPMorgan and to Overweight from Equal-Weight at First Analysis. 2. Gap (GPS) upgraded to Neutral from Sell at Citi, with analyst Paul Lejuez saying concerns of a slowdown at Old Navy appear more priced in at current valuation levels. He raised his price target for the shares to $24 from $22. 3. Gerdau (GGB) upgraded to Overweight from Neutral at JPMorgan with analyst Rodolfo Angele saying the company's business environment has improved. 4. Owens & Minor (OMI) upgraded to Neutral from Underperform at Baird with analyst Eric Coldwell citing its relative underperformance. 5. Toronto-Dominion (TD) upgraded to Outperform from Sector Perform at National Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HPE HP Enterprise
$13.76

-0.28 (-1.99%)

09/06/17
UBSW
09/06/17
NO CHANGE
Target $16
UBSW
Buy
HP Enterprise price target lowered to $16 from $21 at UBS
UBS analyst Steven Milunovich lowered his price target on HP Enterprise to $16 from $21 following better than expected Q3 earnings. The analyst said management provided a mixed outlook but indicated a "significant earnings lift" next year, which will be addressed at its analyst meeting on October 18. Milunovich sees share buybacks and earnings guidance as the next catalysts and likes the company's inexpensive valuation. Milunovich maintained his Buy rating on HP Enterprise shares.
09/06/17
BOFA
09/06/17
DOWNGRADE
Target $13
BOFA
Underperform
HP Enterprise downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst Wamsi Mohan downgradede HP Enterprise to Underperform and cut its price target to $13 from $15 citing FY18 headwinds that include increased investment, a competitive pricing environment, and higher commodity costs. The analyst now sees FY18 free-cash-flow of $1.2B versus $1.7B previously and said execution risk is higher and the company lacks positive catalysts.
09/06/17
JEFF
09/06/17
NO CHANGE
Target $17.5
JEFF
Buy
HP Enterprise free cash flow commentary disappointing, says Jefferies
Jefferies analyst James Kisner says that while HP Enterprise's Q3 results were solid, management commentary around current underlying annual earnings power and FY18 free cash flow were disappointing. More cash restructuring outlays are coming in FY18, Kisner tells investors in a post-earnings research note. The analyst, however, continues to believe that the current valuation reflects investor sentiment that is too bearish. He lowered his price target for HP Enterprise to $17.50 from $22 and reiterates a Buy rating on the shares.
09/06/17
09/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) downgraded to Underperform from Neutral at BofA/Merrill with analyst Wamsi Mohan citing fiscal 2018 headwinds that include increased investment, a competitive pricing environment, and higher commodity costs. 2. Marathon Petroleum (MPC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Roger Read saying he now expects the incentive distribution rights buyout may be at the lower end of the prior 15-20 times range. 3. Verifone (PAY) downgraded to Neutral from Buy at Northcoast with analyst Keith Housum saying he has reduced confidence in the company's ability to grow revenues and increase profitability given the delay in reaching the point of sale market with its new Carbon and Engage platform compared to initial expectations. 4. Mallinckrodt (MNK) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying he believes yesterday's unfavorable district court ruling in Mallinckrodt's suit against Praxair (PX) has increased the risk of an Inomax generic potentially as soon as October 2018, compared to his prior expectation of 2031. 5. BHP Billiton (BHP) downgraded to Underperform from Neutral at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
EFII Electronics for Imaging
$35.25

-0.36 (-1.01%)

09/06/17
LBOW
09/06/17
UPGRADE
LBOW
Neutral
Electronics for Imaging upgraded to Neutral from Underperform at Longbow
09/06/17
CRSS
09/06/17
UPGRADE
CRSS
Buy
Electronics for Imaging upgraded to Buy from Hold at Cross Research
09/06/17
WBLR
09/06/17
INITIATION
WBLR
Outperform
Electronics for Imaging reinstated with an Outperform at William Blair
William Blair analyst Brian Drab reinstated Electronics for Imaging with an Outperform rating. Following management's update, the analyst believes the company's accounting and revenue-recognition issues appear "much less severe" than previous releases indicated.
08/04/17
SIDC
08/04/17
DOWNGRADE
SIDC
Neutral
Electronics for Imaging downgraded to Neutral from Buy at Sidoti
SRPT Sarepta
$41.08

-0.15 (-0.36%)

09/06/17
NOMU
09/06/17
NO CHANGE
Target $84
NOMU
Buy
Sarepta's SRP-4053 could bring additional 8% of DMD market, says Nomura
Nomura Instinet analyst Christopher Marai says data this morning from Sarepta Therapeutics highlight that SRP-4053 more efficiently induces exon-skipping relative to Exondys 51. SRP-4053 may address an additional 8% of the Duchenne muscular dystrophy population, or 1,100 patients in the U.S., Marai tells investors in a research note. The analyst believes peak sales of SRP-4053 could exceed $285M in the U.S. and $236M in Europe. Together, SRP-4053 and SRP-4045 could more than double Sarepta's market opportunity, the analyst contends. He keeps a Buy rating on Sarepta with an $84 price target.
09/06/17
JPMS
09/06/17
NO CHANGE
JPMS
Overweight
Sarepta data important for ending bear thesis, says JPMorgan
JPMorgan analyst Anupam Rama believes this morning's data from Sarepta Therapeutics beat Street expectations and are important for "eliminating the bear thesis on the overall technology platform." The analyst expects the shares to be "up substantially" on the top-line SRP-4053 data. Today's update is an "important step in shifting investor base long-term," Rama told investors in a research note earlier. He reiterated an Overweight rating on Sarepta. The stock in morning trading is up 11% to $45.49.
09/06/17
NEED
09/06/17
NO CHANGE
NEED
Sarepta data reduces risk, uncertainty, says Needham
Needham analyst Chad Messer says that the data on Sarepta's DMD treatment, golodiresen, lowers the uncertainty of the treatment's efficacy and reduces the risk of a pending confirmatory study. He thinks the data also "validates the entire exon skipping platform at Sarepta," which should enable it to introduce treatments that benefit a larger population of patients. Finally, he believes that the data improves the company's position vis a vis payers. The analyst keeps a $75 price target and a Buy rating on the stock.
09/06/17
PIPR
09/06/17
NO CHANGE
Target $55
PIPR
Overweight
Piper ups Sarepta target to $55 on positive golodirsen data
Piper Jaffray analyst Edward Tenthoff raised his price target for Sarepta Therapeutics to $55 citing the "positive" muscle biopsy data from the Phase I/II 4053-101 study of exon 53 skipping drug golodirsen in 25 Duchenne muscular dystrophy boys. The shares in morning trading are up 11%, or $4.56, to $45.67. The analyst views the data as encouraging and keeps an Overweight rating on Sarepta shares.
TRVG trivago
$14.93

-0.58 (-3.74%)

07/12/17
WELS
07/12/17
INITIATION
WELS
Market Perform
trivago initiated with a Market Perform at Wells Fargo
Wells Fargo is upbeat on Trivago's (TRVG) execution and business model. But it is cautious on the stock due to what its says is the stock's above peer valuation and increasing competition from TripAdvisor (TRIP).
07/12/17
07/12/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Marathon Oil (MRO) initiated with an Equal Weight at Stephens. 2. General Dynamics (GD) initiated with a Buy at Berenberg. 3. Brookfield Renewable (BEP) initiated with a Buy at TD Securities. 4. trivago (TRVG) initiated with a Market Perform at Wells Fargo. 5. Shopify (SHOP) initiated with a Hold at Benchmark. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/17
MSCO
05/16/17
NO CHANGE
Target $25
MSCO
Overweight
trivago price target raised to $25 following Q1 beat at Morgan Stanley
Morgan Stanley analyst Brian Nowak said trivago's Q1 best indicates strong business momentum, monetization opportunity and strategic positioning. The analyst expects continued growth in revenue per referral, but at a moderating pace, while improving optimization and monetization. The analyst rates trivago an Overweight.
08/07/17
JPMS
08/07/17
NO CHANGE
Target $23
JPMS
Overweight
trivago earnings selloff a buying opportunity, says JPMorgan
JPMorgan analyst Doug Anmuth recommends using Friday's 19% post-earnings selloff in shares of trivago as a buying opportunity. The analyst sees no structural changes to trivago's platform and views the share pullback as overdone. He reiterates an Overweight rating on the name with a $23 price target.
PLAY Dave & Buster's
$58.14

0.3 (0.52%)

08/30/17
08/30/17
NO CHANGE

Dave & Buster's has reached 'compelling entry point,' says BMO Capital
BMO Capital analyst Andrew Strelzik says that Dave & Buster's has reached a compelling entry point, as he believes that the company's "near-term issues" are "more than adequately reflected" in its stock. He says that the company is well-insulated from competition and has the strongest margin outlook among its peers. The analyst trimmed his price target on the name to $72 from $77 but keeps an Outperform rating on the stock.
09/06/17
BMOC
09/06/17
NO CHANGE
BMOC
Dave & Buster's shares should be bought on weakness, says BMO Capital
After Dave & Buster's reported higher than expected Q2 EPS but lowered its comp sales outlook, BMO Capital analyst AndrewStrelzik says that the company's "underlying margins" rose, while its overall comp growth remained positive and its amusements comp growth came in at "nearly 5%." The analyst estimates that the company's core EBITDA has declined by only $1M-$2M, and he recommends buying the shares on weakness.
09/06/17
ADAM
09/06/17
NO CHANGE
Target $72
ADAM
Buy
Dave & Buster's long-term thesis remains intact, says Canaccord
Canaccord analyst Lynne Collier noted Dave & Buster's reported mixed Q2 results but said her long-term thesis remains intact. She said the company was not immune to the industry slowdown, but it remains one of the most attractive names to own in the restaurant business. Collier reiterates her Buy rating but lowered her price target to $72 from $75 on Dave & Buster's shares.
09/06/17
RHCO
09/06/17
NO CHANGE
RHCO
Dave & Buster's should be bought on any weakness, says SunTrust
SunTrust analyst Jake Bartlett says that Dave & Buster's should be bought on any weakness following its same-store sales miss. The analyst says that the midpoint of the company's 2H17 SSS guidance "is roughly inline with consensus expectations heading into results" He notes that the guidance was negatively affected by tough compares and by Hurricane Harvey. The analyst keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

RTMVY

Rightmove

$54.79

0.76 (1.41%)

04:47
11/20/17
11/20
04:47
11/20/17
04:47
Initiation
Rightmove initiated  »

Rightmove initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

03:05
11/20/17
11/20
03:05
11/20/17
03:05
General news
FX Update: EUR-USD and euro crosses took a clobber »

FX Update: EUR-USD and…

TWX

Time Warner

$88.72

0.71 (0.81%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

20:02
11/19/17
11/19
20:02
11/19/17
20:02
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

TWX

Time Warner

$88.72

0.71 (0.81%)

GE

General Electric

$18.21

-0.04 (-0.22%)

IBM

IBM

$148.97

-0.15 (-0.10%)

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

HMC

Honda

$32.62

0.02 (0.06%)

GLPG

Galapagos NV

$90.83

-0.66 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 14

    Dec

BABA

Alibaba

$185.13

-0.3 (-0.16%)

18:01
11/19/17
11/19
18:01
11/19/17
18:01
Hot Stocks
Alibaba, Auchan Retail, Ruentex form new retail strategic alliance »

Alibaba, Auchan Retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, CMCSA

Comcast

$36.16

-0.91 (-2.45%)

17:32
11/19/17
11/19
17:32
11/19/17
17:32
Hot Stocks
Box Office Battle: 'Justice League' wins weekend with just $96M »

Warner Bros.' (TWX)…

TWX

Time Warner

$88.72

0.71 (0.81%)

CMCSA

Comcast

$36.16

-0.91 (-2.45%)

CMCSK

Comcast

SNE

Sony

$46.17

0.07 (0.15%)

FOX

21st Century Fox

$30.48

1.88 (6.57%)

FOXA

21st Century Fox

$31.15

1.83 (6.24%)

LGF.A

Lionsgate

$32.59

1.55 (4.99%)

DIS

Disney

$103.44

-0.16 (-0.15%)

VIAB

Viacom

$26.15

2.46 (10.38%)

VIA

Viacom

$33.00

2.9 (9.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

17:10
11/19/17
11/19
17:10
11/19/17
17:10
Periodicals
GE yet to decide which directors will lose seats, WSJ reports »

A housecleaning at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$90.83

-0.66 (-0.72%)

17:01
11/19/17
11/19
17:01
11/19/17
17:01
Hot Stocks
Galapagos NV reports positive topline results from ALBATROSS with GLPG2222 »

Galapagos NV reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$262.26

-1.44 (-0.55%)

16:55
11/19/17
11/19
16:55
11/19/17
16:55
Hot Stocks
Boeing, Avolon finalize deal for 75 737 MAX airplanes »

Boeing and Avolon have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBLK

Star Bulk Carriers

$9.60

0.19 (2.02%)

16:53
11/19/17
11/19
16:53
11/19/17
16:53
Earnings
Star Bulk Carriers reports Q3 adjusted EPS (8c), consensus (5c) »

"We released today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

BDRBF

Bombardier

$2.43

0.0007 (0.03%)

16:22
11/19/17
11/19
16:22
11/19/17
16:22
Hot Stocks
Bombardier predicts Latin America's 60-150 seat aircraft fleet will double »

Bombardier Commercial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TSLA

Tesla

$315.05

2.55 (0.82%)

10:21
11/18/17
11/18
10:21
11/18/17
10:21
Periodicals
Tesla new super car to cost $200,000, Recode says »

Alongside its new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 16

    Jan

GT

Goodyear Tire

$29.94

0.63 (2.15%)

10:17
11/18/17
11/18
10:17
11/18/17
10:17
Hot Stocks
Goodyear Tire, NASCAR extend relationship »

NASCAR and Goodyear Tire…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Jan

  • 16

    Jan

HMC

Honda

$32.62

0.02 (0.06%)

10:05
11/18/17
11/18
10:05
11/18/17
10:05
Periodicals
Honda recalls 900,000 minivans on tip forward seats, Reuters says »

Honda Motor is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$88.43

-0.82 (-0.92%)

09:48
11/18/17
11/18
09:48
11/18/17
09:48
Periodicals
Activist investors Nelson Peltz still in P&G picture, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

, GE

General Electric

$18.21

-0.04 (-0.22%)

09:39
11/18/17
11/18
09:39
11/18/17
09:39
Periodicals
Buy Baker Hughes, Barron's says »

While it is "not…

BHGE

Baker Hughes

$30.91

0.76 (2.52%)

GE

General Electric

$18.21

-0.04 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CSCO

Cisco

$35.90

0.02 (0.06%)

09:19
11/18/17
11/18
09:19
11/18/17
09:19
Periodicals
More needed for Cisco to have 'groove back,' Barron's says »

While the Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

IBM

IBM

$148.97

-0.15 (-0.10%)

09:10
11/18/17
11/18
09:10
11/18/17
09:10
Periodicals
IBM could be next to fetch higher valuation, Barron's says »

Investors are warming to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

GE

General Electric

$18.21

-0.04 (-0.22%)

09:05
11/18/17
11/18
09:05
11/18/17
09:05
Periodicals
Option play offer some help given GE dividend, depressed stock, Barron's says »

While wagering against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.04 (-0.22%)

09:00
11/18/17
11/18
09:00
11/18/17
09:00
Periodicals
Risk remains after GE dividend cut, Barron's says »

While buying General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$88.72

0.71 (0.81%)

, T

AT&T

$34.51

-0.01 (-0.03%)

08:21
11/18/17
11/18
08:21
11/18/17
08:21
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

TWX

Time Warner

$88.72

0.71 (0.81%)

T

AT&T

$34.51

-0.01 (-0.03%)

NYT

New York Times

$17.65

0.05 (0.28%)

TEX

Terex

$44.82

0.8 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

TPIC

TPI Composites

$19.06

-0.97 (-4.84%)

07:25
11/18/17
11/18
07:25
11/18/17
07:25
Conference/Events
TPI Composites to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SYNA

Synaptics

$38.21

0.57 (1.51%)

04:55
11/18/17
11/18
04:55
11/18/17
04:55
Conference/Events
Synaptics management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

, BRCD

Brocade

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

MKSI

MKS Instruments

$103.50

-0.35 (-0.34%)

BRCD

Brocade

IVR

Invesco Mortgage

$17.36

0.07 (0.40%)

AVGO

Broadcom

$271.86

-0.25 (-0.09%)

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 06

    Dec

WGL

WGL Holdings

$84.32

-0.14 (-0.17%)

18:01
11/17/17
11/17
18:01
11/17/17
18:01
Earnings
WGL Holdings reports Q4 adjusted EPS (17c), consensus (19c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

, LMOS

Lumos Networks

17:58
11/17/17
11/17
17:58
11/17/17
17:58
Hot Stocks
Tactile Systems to replace Lumos Networks in S&P 600 at open on 11/22 »

EQT Infrastructure…

TCMD

Tactile Systems

$25.98

-0.23 (-0.88%)

LMOS

Lumos Networks

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.